SECsense Logo

Keros Therapeutics 8-K Report: Key Events You Need to Know!

$KROS
Form 8-K
Filed on: 2025-01-15
Source
Keros Therapeutics 8-K Report: Key Events You Need to Know!

Based on the provided section of the financial report, here are the key points extracted:

  1. Entity Information:
  • Company Name: Keros Therapeutics, Inc.
  • CIK Number: 0001664710
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-39264
  • Employer Identification Number (EIN): 81-1173868
  • Address: 1050 Waltham Street, Suite 302, Lexington, MA 02421
  • Phone Number: 617-314-6297
  1. Filing Information:
  • Form Type: 8-K (a current report used to disclose important events)
  • Filing Date: January 15, 2025
  1. Security Information:
  • Type of Security: Common Stock
  • Par Value: $0.0001 per share
  • Ticker Symbol: KROS
  • Exchange: NASDAQ
  1. Period of Report:
  • Start Date: January 15, 2025
  • End Date: January 15, 2025

Insights:

  • The report indicates a significant event or announcement from Keros Therapeutics, as it is filed under Form 8-K, which typically covers unscheduled material events that are important to shareholders.
  • Keros Therapeutics is publicly traded on NASDAQ, which suggests it is subject to regular financial disclosures and regulatory oversight.
  • The report’s date indicates it is a future filing, suggesting planned or upcoming disclosures that may affect investor sentiment or stock performance.

This information would be relevant for investors, analysts, and stakeholders seeking to understand recent developments related to Keros Therapeutics, Inc.